Published in Malar J on May 24, 2010
Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev (2011) 5.15
Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol (2014) 2.92
A method of active case detection to target reservoirs of asymptomatic malaria and gametocyte carriers in a rural area in Southern Province, Zambia. Malar J (2010) 2.83
Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue. Proc Natl Acad Sci U S A (2011) 2.83
Experimental human challenge infections can accelerate clinical malaria vaccine development. Nat Rev Immunol (2011) 2.53
The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites. PLoS Med (2012) 2.42
The potential contribution of mass treatment to the control of Plasmodium falciparum malaria. PLoS One (2011) 1.95
A specific inhibitor of PfCDPK4 blocks malaria transmission: chemical-genetic validation. J Infect Dis (2013) 1.71
A sub-microscopic gametocyte reservoir can sustain malaria transmission. PLoS One (2011) 1.67
Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence. J Infect Dis (2013) 1.52
Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis. Nat Commun (2014) 1.51
A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania. Malar J (2011) 1.42
Immune mechanisms in malaria: new insights in vaccine development. Nat Med (2013) 1.40
Rationale for short course primaquine in Africa to interrupt malaria transmission. Malar J (2012) 1.35
Antimalarial drug discovery - the path towards eradication. Parasitology (2013) 1.19
Identification of MMV malaria box inhibitors of plasmodium falciparum early-stage gametocytes using a luciferase-based high-throughput assay. Antimicrob Agents Chemother (2013) 1.18
Blood-Stage Parasitaemia and Age Determine Plasmodium falciparum and P. vivax Gametocytaemia in Papua New Guinea. PLoS One (2015) 1.15
Comparison of detection methods to estimate asexual Plasmodium falciparum parasite prevalence and gametocyte carriage in a community survey in Tanzania. Malar J (2014) 1.12
Population-wide malaria testing and treatment with rapid diagnostic tests and artemether-lumefantrine in southern Zambia: a community randomized step-wedge control trial design. Am J Trop Med Hyg (2015) 1.12
A male and female gametocyte functional viability assay to identify biologically relevant malaria transmission-blocking drugs. Antimicrob Agents Chemother (2014) 1.10
Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials. Malar J (2013) 1.10
Ivermectin inhibits the sporogony of Plasmodium falciparum in Anopheles gambiae. Malar J (2012) 1.10
Declining burden of malaria over two decades in a rural community of Muheza district, north-eastern Tanzania. Malar J (2013) 1.07
Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children. PLoS One (2014) 1.07
The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania. PLoS One (2010) 1.06
Plasmodium falciparum gametocyte development 1 (Pfgdv1) and gametocytogenesis early gene identification and commitment to sexual development. PLoS Pathog (2012) 1.05
Recent advances in malaria drug discovery. Bioorg Med Chem Lett (2013) 1.04
Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria. Malar J (2014) 1.01
Modeling within-host effects of drugs on Plasmodium falciparum transmission and prospects for malaria elimination. PLoS Comput Biol (2014) 1.01
Malaria's missing number: calculating the human component of R0 by a within-host mechanistic model of Plasmodium falciparum infection and transmission. PLoS Comput Biol (2013) 0.99
Sub-microscopic gametocyte carriage in febrile children living in different areas of Gabon. Malar J (2013) 0.96
Marked age-dependent prevalence of symptomatic and patent infections and complexity of distribution of human Plasmodium species in central Vietnam. Am J Trop Med Hyg (2012) 0.96
Development of potent and selective Plasmodium falciparum calcium-dependent protein kinase 4 (PfCDPK4) inhibitors that block the transmission of malaria to mosquitoes. Eur J Med Chem (2014) 0.95
High-Throughput Assay and Discovery of Small Molecules that Interrupt Malaria Transmission. Cell Host Microbe (2015) 0.92
Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission. Cochrane Database Syst Rev (2014) 0.91
Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission. Cochrane Database Syst Rev (2015) 0.90
Human-to-mosquito transmission efficiency increases as malaria is controlled. Nat Commun (2015) 0.89
Comparison of three methods for detection of gametocytes in Melanesian children treated for uncomplicated malaria. Malar J (2014) 0.89
A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission. Malar J (2014) 0.89
Lead clinical and preclinical antimalarial drugs can significantly reduce sporozoite transmission to vertebrate populations. Antimicrob Agents Chemother (2014) 0.88
Lysine acetylation in sexual stage malaria parasites is a target for antimalarial small molecules. Antimicrob Agents Chemother (2014) 0.88
Simultaneous detection of Plasmodium vivax and Plasmodium falciparum gametocytes in clinical isolates by multiplex-nested RT-PCR. Malar J (2012) 0.88
Targeting Human Transmission Biology for Malaria Elimination. PLoS Pathog (2015) 0.88
Malaria elimination: surveillance and response. Pathog Glob Health (2012) 0.87
A simple and predictive phenotypic High Content Imaging assay for Plasmodium falciparum mature gametocytes to identify malaria transmission blocking compounds. Sci Rep (2015) 0.86
The Gametocytocidal Efficacy of Different Single Doses of Primaquine with Dihydroartemisinin-piperaquine in Asymptomatic Parasite Carriers in The Gambia: A Randomized Controlled Trial. EBioMedicine (2016) 0.85
Effect of fluorescent dyes on in vitro-differentiated, late-stage Plasmodium falciparum gametocytes. Antimicrob Agents Chemother (2014) 0.85
Pregnant women are a reservoir of malaria transmission in Blantyre, Malawi. Malar J (2014) 0.85
Modelling heterogeneity in malaria transmission using large sparse spatio-temporal entomological data. Glob Health Action (2014) 0.84
Exploration of in vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in under fives in Tabora region, Tanzania. Malar J (2013) 0.84
A semi-automated luminescence based standard membrane feeding assay identifies novel small molecules that inhibit transmission of malaria parasites by mosquitoes. Sci Rep (2015) 0.83
Translational regulation during stage transitions in malaria parasites. Ann N Y Acad Sci (2014) 0.82
Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination. Parasitol Res (2014) 0.81
Sexual development in Plasmodium parasites: knowing when it's time to commit. Nat Rev Microbiol (2015) 0.81
Fitness components and natural selection: why are there different patterns on the emergence of drug resistance in Plasmodium falciparum and Plasmodium vivax? Malar J (2013) 0.81
Nonrandomized controlled trial of artesunate plus sulfadoxine-pyrimethamine with or without primaquine for preventing posttreatment circulation of Plasmodium falciparum gametocytes. Antimicrob Agents Chemother (2013) 0.80
4-(1H)-Quinolones and 1,2,3,4-Tetrahydroacridin-9(10H)-ones prevent the transmission of Plasmodium falciparum to Anopheles freeborni. Antimicrob Agents Chemother (2013) 0.80
Plasmodium falciparum Gametocyte-Specific Antibody Profiling Reveals Boosting through Natural Infection and Identifies Potential Markers of Gametocyte Exposure. Infect Immun (2015) 0.80
Gametocyte clearance dynamics following oral artesunate treatment of uncomplicated falciparum malaria in Malian children. Parasite (2016) 0.79
How selection forces dictate the variant surface antigens used by malaria parasites. J R Soc Interface (2011) 0.79
Gametocyte carriage in Plasmodium falciparum-infected travellers. Malar J (2013) 0.79
In Vitro Activities of Primaquine-Schizonticide Combinations on Asexual Blood Stages and Gametocytes of Plasmodium falciparum. Antimicrob Agents Chemother (2015) 0.79
Risk factors for Plasmodium falciparum gametocyte positivity in a longitudinal cohort. PLoS One (2015) 0.78
The antimalarial drug primaquine targets Fe-S cluster proteins and yeast respiratory growth. Redox Biol (2015) 0.78
Transmission blocking activity of Azadirachta indica and Guiera senegalensis extracts on the sporogonic development of Plasmodium falciparum field isolates in Anopheles coluzzii mosquitoes. Parasit Vectors (2014) 0.77
Epidemiology of Plasmodium falciparum gametocytemia in India: prevalence, age structure, risk factors and the role of a predictive score for detection. Trop Med Int Health (2013) 0.77
Transmission-blocking strategies: the roadmap from laboratory bench to the community. Malar J (2016) 0.77
Gametocyte Clearance Kinetics Determined by Quantitative Magnetic Fractionation in Melanesian Children with Uncomplicated Malaria Treated with Artemisinin Combination Therapy. Antimicrob Agents Chemother (2015) 0.76
Plasmodium transmission blocking activities of Vernonia amygdalina extracts and isolated compounds. Malar J (2015) 0.76
Application of magnetic cytosmear for the estimation of Plasmodium falciparum gametocyte density and detection of asexual stages in asymptomatic children. Malar J (2016) 0.75
Multi-year optimization of malaria intervention: a mathematical model. Malar J (2016) 0.75
Comparison of methods for detecting asymptomatic malaria infections in the China-Myanmar border area. Malar J (2017) 0.75
Malaria parasite clearance. Malar J (2017) 0.75
Prevalence of Plasmodium falciparum transmission reducing immunity among primary school children in a malaria moderate transmission region in Zimbabwe. Acta Trop (2016) 0.75
Associations between Season and Gametocyte Dynamics in Chronic Plasmodium falciparum Infections. PLoS One (2016) 0.75
Single dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission in Cambodia: An open-label randomized trial. PLoS One (2017) 0.75
Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling. PLoS Med (2016) 0.75
Transmission-Blocking Potential of MEFAS, a Hybrid Compound Derived from Artesunate and Mefloquine. Antimicrob Agents Chemother (2016) 0.75
A validated agent-based model to study the spatial and temporal heterogeneities of malaria incidence in the rainforest environment. Malar J (2015) 0.75
Application of multi-target phytotherapeutic concept in malaria drug discovery: a systems biology approach in biomarker identification. Biomark Res (2016) 0.75
The Nonartemisinin Sesquiterpene Lactones Parthenin and Parthenolide Block Plasmodium falciparum Sexual Stage Transmission. Antimicrob Agents Chemother (2016) 0.75
Mathematical Modelling to Guide Drug Development for Malaria Elimination. Trends Parasitol (2016) 0.75
Modelling the benefits of long-acting or transmission-blocking drugs for reducing Plasmodium falciparum transmission by case management or by mass treatment. Malar J (2017) 0.75
Translational Control in the Latency of Apicomplexan Parasites. Trends Parasitol (2017) 0.75
Life-span of in vitro differentiated Plasmodium falciparum gametocytes. Malar J (2017) 0.75
Extended-spectrum antiprotozoal bumped kinase inhibitors: A review. Exp Parasitol (2017) 0.75
Effects of liver-stage clearance by Primaquine on gametocyte carriage of Plasmodium vivax and P. falciparum. PLoS Negl Trop Dis (2017) 0.75
Qinghaosu (artemisinin): the price of success. Science (2008) 8.25
Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med (2005) 4.65
Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. Am J Trop Med Hyg (2007) 4.20
Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. PLoS Med (2005) 3.91
The role of anti-malarial drugs in eliminating malaria. Malar J (2008) 3.45
Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J Infect Dis (2001) 3.36
Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane Database Syst Rev (2009) 3.26
Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. J Infect Dis (2006) 3.17
Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLoS One (2009) 2.94
Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission. PLoS One (2009) 2.87
Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Malar J (2004) 2.84
Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. PLoS Med (2008) 2.78
Antimalarial drug toxicity: a review. Drug Saf (2004) 2.76
Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Malar J (2008) 2.68
The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion. Trends Parasitol (2006) 2.53
Primaquine revisited six decades after its discovery. Eur J Med Chem (2008) 2.43
Gametocytogenesis: the puberty of Plasmodium falciparum. Malar J (2004) 2.29
Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria. Antimicrob Agents Chemother (2004) 2.17
Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS One (2007) 2.17
Quantification of Plasmodium falciparum gametocytes in differential stages of development by quantitative nucleic acid sequence-based amplification. Mol Biochem Parasitol (2004) 2.16
Plasmodium falciparum gametocytes: their longevity and infectivity. Parasitology (1977) 2.02
Real-time nucleic acid sequence-based amplification is more convenient than real-time PCR for quantification of Plasmodium falciparum. J Clin Microbiol (2005) 1.96
Antimalarial drugs and the mosquito transmission of Plasmodium. Int J Parasitol (1997) 1.92
The treatment of Plasmodium falciparum infection with chloroquine, with a note on infectivity to mosquitoes of primaquine- and pyrimethamine-treated cases. Am J Hyg (1956) 1.83
Unstable malaria in Sudan: the influence of the dry season. Clone multiplicity of Plasmodium falciparum infections in individuals exposed to variable levels of disease transmission. Trans R Soc Trop Med Hyg (1999) 1.82
Impact of genetic complexity on longevity and gametocytogenesis of Plasmodium falciparum during the dry and transmission-free season of eastern Sudan. Int J Parasitol (2004) 1.80
Gametocytes: insights gained during a decade of molecular monitoring. Trends Parasitol (2008) 1.79
Genesis, sequestration and survival of Plasmodium falciparum gametocytes: parameter estimates from fitting a model to malariatherapy data. Trans R Soc Trop Med Hyg (2001) 1.75
Malaria transmission-blocking vaccines--how can their development be supported? Nat Med (2000) 1.69
Dynamics of gametocytes among Plasmodium falciparum clones in natural infections in an area of highly seasonal transmission. J Infect Dis (2002) 1.66
Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations. Malar J (2009) 1.62
Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria. Am J Epidemiol (2002) 1.48
Influence of consecutive-day blood sampling on polymerase chain reaction-adjusted parasitological cure rates in an antimalarial-drug trial conducted in Tanzania. J Infect Dis (2007) 1.45
Transmission-blocking activities of quinine, primaquine, and artesunate. Antimicrob Agents Chemother (2006) 1.43
Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu on Plasmodium falciparum. Parasitol Res (1990) 1.41
Increased Plasmodium falciparum gametocyte production in mixed infections with P. malariae. Am J Trop Med Hyg (2008) 1.35
Population pharmacokinetics of artesunate and amodiaquine in African children. Malar J (2009) 1.26
Plasmodium falciparum: infectivity of cultured, synchronized gametocytes to mosquitoes. Exp Parasitol (1999) 1.13
Malaria transmission-blocking vaccines: the bonus of effective malaria control. Microbes Infect (2007) 1.11
Specific and nonspecific responses to Plasmodium falciparum blood-stage parasites and observations on the gametocytemia in schoolchildren living in a malaria-endemic area of Mozambique. Am J Trop Med Hyg (1995) 0.96
Lack of sex effect on the pharmacokinetics of primaquine. Am J Trop Med Hyg (2006) 0.94
The effect of a single dose of pyrimethamine and primaquine in combination upon gametocytes and sporogony of Laverania falcipara (Plasmodium falciparum) in Liberia. Bull World Health Organ (1961) 0.87
Pandemic potential of a strain of influenza A (H1N1): early findings. Science (2009) 26.24
Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science (2003) 12.26
Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ (2004) 11.96
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med (2011) 10.79
Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet (2003) 10.74
Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial. BMJ (2007) 10.03
Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ (2009) 6.66
Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med (2009) 6.65
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med (2012) 6.64
Operational strategies to achieve and maintain malaria elimination. Lancet (2010) 6.48
The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet (2011) 5.87
Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysis. J Infect Dis (2009) 5.73
Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. PLoS Med (2010) 5.71
Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun (2012) 5.34
Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev (2011) 5.15
Hitting hotspots: spatial targeting of malaria for control and elimination. PLoS Med (2012) 4.68
Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. JAMA (2005) 4.57
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature (2012) 4.37
Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet (2009) 4.30
Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet (2003) 4.26
Protection against a malaria challenge by sporozoite inoculation. N Engl J Med (2009) 4.03
Identification of hot spots of malaria transmission for targeted malaria control. J Infect Dis (2010) 3.86
Public health. Public health risk from the avian H5N1 influenza epidemic. Science (2004) 3.71
Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes. J Exp Med (2004) 3.63
Serology: a robust indicator of malaria transmission intensity? Trends Parasitol (2007) 3.63
Human Infections with Plasmodium knowlesi, the Philippines. Emerg Infect Dis (2008) 3.55
The contribution of microscopy to targeting antimalarial treatment in a low transmission area of Tanzania. Malar J (2006) 3.31
Managing and reducing uncertainty in an emerging influenza pandemic. N Engl J Med (2009) 3.31
CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater. J Acquir Immune Defic Syndr (2007) 3.18
Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar J (2008) 3.02
Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLoS One (2009) 2.94
Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis. PLoS One (2010) 2.90
Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission. PLoS One (2009) 2.87
Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. PLoS Med (2008) 2.78
Mortality and progression to AIDS after starting highly active antiretroviral therapy. AIDS (2003) 2.78
Sub-microscopic malaria cases and mixed malaria infection in a remote area of high malaria endemicity in Rattanakiri province, Cambodia: implication for malaria elimination. Malar J (2010) 2.75
Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Malar J (2008) 2.68
Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008. Emerg Infect Dis (2010) 2.59
Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Antimicrob Agents Chemother (2003) 2.57
The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion. Trends Parasitol (2006) 2.53
Costs and cost-effectiveness of malaria control interventions--a systematic review. Malar J (2011) 2.53
Using serological measures to monitor changes in malaria transmission in Vanuatu. Malar J (2010) 2.47
Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol (2004) 2.47
Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. Philos Trans R Soc Lond B Biol Sci (2004) 2.45
The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med (2004) 2.36
Developmental origins of midlife physical performance: evidence from a British birth cohort. Am J Epidemiol (2006) 2.35
TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci U S A (2007) 2.28
Knowledge of malaria influences the use of insecticide treated nets but not intermittent presumptive treatment by pregnant women in Tanzania. Malar J (2004) 2.25
A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese children. PLoS One (2008) 2.24
Estimating the potential public health impact of seasonal malaria chemoprevention in African children. Nat Commun (2012) 2.17
Predicting mosquito infection from Plasmodium falciparum gametocyte density and estimating the reservoir of infection. Elife (2013) 2.17
Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS One (2007) 2.17
Quantification of Plasmodium falciparum gametocytes in differential stages of development by quantitative nucleic acid sequence-based amplification. Mol Biochem Parasitol (2004) 2.16
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals. Antimicrob Agents Chemother (2010) 2.15
Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data. Lancet Infect Dis (2013) 2.00
Modelling the impact of vector control interventions on Anopheles gambiae population dynamics. Parasit Vectors (2011) 1.99
Real-time nucleic acid sequence-based amplification is more convenient than real-time PCR for quantification of Plasmodium falciparum. J Clin Microbiol (2005) 1.96
The potential contribution of mass treatment to the control of Plasmodium falciparum malaria. PLoS One (2011) 1.95
The importance of mosquito behavioural adaptations to malaria control in Africa. Evolution (2013) 1.93
Protein export marks the early phase of gametocytogenesis of the human malaria parasite Plasmodium falciparum. Mol Cell Proteomics (2010) 1.92
Determination of the processes driving the acquisition of immunity to malaria using a mathematical transmission model. PLoS Comput Biol (2007) 1.87
Surveillance for malaria elimination in Swaziland: a national cross-sectional study using pooled PCR and serology. PLoS One (2012) 1.81
Developmental origins of midlife grip strength: findings from a birth cohort study. J Gerontol A Biol Sci Med Sci (2006) 1.77
(Sub)microscopic Plasmodium falciparum gametocytaemia in Kenyan children after treatment with sulphadoxine-pyrimethamine monotherapy or in combination with artesunate. Int J Parasitol (2006) 1.75
Evaluation of uptake and attitude to voluntary counseling and testing among health care professional students in Kilimanjaro region, Tanzania. BMC Public Health (2009) 1.73
Estimating the annual entomological inoculation rate for Plasmodium falciparum transmitted by Anopheles gambiae s.l. using three sampling methods in three sites in Uganda. Malar J (2014) 1.73
The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia. Trans R Soc Trop Med Hyg (2003) 1.69
Loss of population levels of immunity to malaria as a result of exposure-reducing interventions: consequences for interpretation of disease trends. PLoS One (2009) 1.68
Epidemiology of subpatent Plasmodium falciparum infection: implications for detection of hotspots with imperfect diagnostics. Malar J (2013) 1.64
Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum. PLoS Clin Trials (2006) 1.63
Association of sub-microscopic malaria parasite carriage with transmission intensity in north-eastern Tanzania. Malar J (2011) 1.63
The suitability of clay pots for indoor sampling of mosquitoes in an arid area in northern Tanzania. Acta Trop (2009) 1.62
Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial. J Infect Dis (2013) 1.61
Identification of individuals with gonorrhoea within sexual networks: a population-based study. Lancet (2006) 1.61
The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg (2002) 1.60
Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery. PLoS One (2011) 1.60
Mosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriers. PLoS One (2012) 1.57
Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination. Malar J (2013) 1.57
Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Alhydrogel, Montanide ISA 720 or AS02. PLoS One (2008) 1.56
Establishment of the 1st World Health Organization International Standard for Plasmodium falciparum DNA for nucleic acid amplification technique (NAT)-based assays. Malar J (2008) 1.52
Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence. J Infect Dis (2013) 1.52